Deleted Tweet from Scott Gottlieb, R-D.C.
Deleted Tweet from Scott Gottlieb, M.D.
SteveFDA (R-D.C.)
@SGottliebFDA
Politwoops no longer follows this account.
In addition to generic competition, we can’t underestimate benefit of new drug competition when a 2nd to market drug enters a class. We’re pursuing policies to reduce first/only product monopolies; working on analysis of impact of 2nd to market competitio
It looks like this tweet was not replaced.